Profile data is unavailable for this security.
About the company
INIFY Laboratories AB is a Sweden-based medical research company that provides cancer diagnostics through laboratory services within pathology. The Company uses a fully digital, standardized and Artificial Intelligence (AI)- supported workflow to optimize quality and response times, initially within prostate. The service includes the whole chain of sample handling: from logistics, to sample preparation, to reporting by a pathologist from either Inify Laboratories or the customer’s organization. INIFY Laboratories' laboratory in Solna, Sweden is intended to provide two types of analyses of prostate Biopsy Specimens to clients: Full pathology Report signed by an INIFY subspecialized pathologist and Whole Slide Images (WSI) generation and result of Pathology Decision Support Tool (PDST) analysis only. The Company origins from ContextVision.
- Revenue in NOK (TTM)3.45m
- Net income in NOK-51.78m
- Incorporated2021
- Employees23.00
- LocationINIFY Laboratories ABScheeles vag 3SOLNA 171 65SwedenSWE
- Phone+46 8267330
- Websitehttps://www.inify.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vo2 Cap Holding AB (publ) | 344.92m | 3.23m | 165.97m | 103.00 | 47.81 | 0.7014 | 3.23 | 0.4812 | 0.0607 | 0.0607 | 6.50 | 4.13 | 0.7493 | -- | 7.03 | 3,328,282.00 | 0.7023 | -0.2564 | 0.9347 | -0.3839 | 34.62 | 23.36 | 0.9373 | -0.2409 | -- | 1.18 | 0.1564 | -- | -26.09 | 85.65 | -57.92 | -- | -17.96 | -- |
BibbInstruments AB | 0.00 | -11.51m | 169.83m | -- | -- | 5.43 | -- | -- | -0.4401 | -0.4401 | 0.00 | 1.06 | 0.00 | -- | -- | -- | -36.33 | -39.57 | -39.77 | -42.71 | -- | 59.36 | -- | -8,032.40 | 2.03 | -- | 0.00 | -- | -- | -- | 2.72 | -- | -1.94 | -- |
Phase Holographic Imaging PHI AB | 10.76m | -22.68m | 172.88m | 17.00 | -- | 15.78 | -- | 16.07 | -1.03 | -1.03 | 0.476 | 0.4158 | 0.2825 | 0.876 | 1.83 | -- | -59.55 | -62.29 | -71.77 | -77.87 | 65.56 | 60.35 | -210.82 | -402.73 | 0.8236 | -2.76 | 0.6255 | -- | 21.19 | 17.35 | 8.65 | -- | -0.0924 | -- |
Episurf Medical AB | 11.07m | -92.66m | 179.89m | 25.00 | -- | 1.25 | -- | 16.25 | -0.266 | -0.266 | 0.0318 | 0.1861 | 0.0852 | -- | 5.24 | 392,857.20 | -71.42 | -47.46 | -81.48 | -52.01 | -- | -- | -838.18 | -1,019.29 | 2.54 | -- | 0.068 | -- | 53.62 | 19.78 | -22.64 | -- | -0.4158 | -- |
Nexstim Oyj | 82.52m | -15.12m | 222.66m | 37.00 | -- | 6.89 | -- | 2.70 | -0.1956 | -0.1956 | 1.09 | 0.4192 | 0.7211 | 0.2708 | 3.76 | 195,845.70 | -13.21 | -26.77 | -20.24 | -43.90 | 96.38 | 92.11 | -18.32 | -38.38 | 1.42 | -12.60 | 0.61 | -- | -23.94 | 22.08 | -201.58 | -- | 19.51 | -- |
Arcoma AB | 172.95m | 9.46m | 224.20m | 31.00 | 23.70 | 4.22 | 13.51 | 1.30 | 0.713 | 0.713 | 13.04 | 4.01 | 1.81 | 3.71 | 6.93 | 5,544,871.00 | 9.92 | 1.12 | 18.49 | 2.01 | 36.83 | 37.66 | 5.47 | 0.7568 | 0.9788 | 11.95 | 0.0475 | 0.00 | 30.36 | 6.41 | 34.81 | -- | 22.75 | -- |
SpectraCure AB (publ) | 2.67m | -21.19m | 236.01m | 13.00 | -- | 1.89 | -- | 88.52 | -0.2168 | -0.2168 | 0.0273 | 1.28 | 0.0178 | -- | 19.00 | 176,666.70 | -14.11 | -12.75 | -15.44 | -13.62 | 393.13 | 195.30 | -794.75 | -494.40 | -- | -- | 0.0499 | -- | -3.30 | -- | 19.46 | -- | -- | -- |
Scandinavian Medical Solutions A/S | 301.58m | 8.20m | 251.95m | 25.00 | 30.56 | 2.13 | 13.62 | 0.8354 | 0.1963 | 0.1963 | 7.22 | 2.81 | 1.38 | 1.89 | 11.35 | -- | 3.75 | -- | 6.15 | -- | 24.48 | -- | 2.72 | -- | 0.4307 | 5.54 | 0.3473 | -- | 72.98 | -- | 7.49 | -- | -- | -- |
Micropos Medical AB (publ) | 1.78m | -23.90m | 297.31m | 9.00 | -- | 11.49 | -- | 166.76 | -0.258 | -0.258 | 0.0149 | 0.1692 | 0.0529 | 0.0999 | 0.7758 | 221,497.50 | -70.97 | -64.24 | -89.99 | -82.27 | 74.48 | 114.76 | -1,340.85 | -767.57 | 4.04 | -- | 0.0146 | -- | 50.23 | 5.94 | -26.57 | -- | -- | -- |
Ortoma AB | 42.84m | -23.26m | 311.47m | 7.00 | -- | 1.93 | -- | 7.27 | -0.5435 | -0.5435 | 1.27 | 4.53 | 0.2364 | -9.92 | 18.51 | 6,082,966.00 | -12.83 | -10.45 | -13.90 | -11.64 | 129.28 | 339.86 | -54.29 | -175.52 | 3.01 | -- | 0.00 | -- | -- | -- | -38.87 | -- | 14.14 | -- |
INIFY Laboratories AB | 3.45m | -51.78m | 320.56m | 23.00 | -- | 4.35 | -- | 93.05 | -1.14 | -1.14 | 0.0762 | 1.63 | 0.032 | 2.99 | 0.6608 | -- | -48.10 | -- | -48.10 | -- | 76.42 | -- | -1,503.10 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
Bactiquant A/S | 18.79m | -20.01m | 346.22m | -- | -- | 15.73 | -- | 18.43 | -0.6358 | -0.6358 | 0.5971 | 0.6133 | 0.5055 | 3.67 | 2.83 | -- | -53.83 | -41.26 | -62.59 | -47.16 | -6.14 | 12.89 | -106.51 | -71.77 | 5.43 | -8.54 | 0.0431 | -- | -0.689 | -- | 7.62 | -- | -- | -- |
Karolinska Development AB | 1.95m | 33.81m | 389.75m | 8.00 | 11.63 | 0.3133 | 11.24 | 199.99 | 0.1245 | 0.1245 | 0.0072 | 4.62 | 0.0016 | -- | 1.66 | 242,125.00 | 2.71 | 3.37 | 2.73 | 3.83 | -- | -- | 1,734.95 | 1,466.36 | -- | -- | 0.0023 | 0.00 | -12.43 | -8.10 | 106.11 | -29.31 | -- | -- |
Boule Diagnostics AB | 579.56m | 27.14m | 394.62m | 233.00 | 14.71 | 0.7876 | 7.13 | 0.6809 | 0.6868 | 0.6868 | 14.79 | 12.82 | 0.7378 | 4.35 | 3.53 | 2,526,443.00 | 3.44 | 1.67 | 4.73 | 2.40 | 43.73 | 43.50 | 4.67 | 2.04 | 1.05 | 4.77 | 0.2638 | 42.24 | 4.24 | 6.13 | 96.24 | -9.45 | -9.74 | -- |
Q linea AB | 5.93m | -225.30m | 463.29m | 126.00 | -- | 3.44 | -- | 78.12 | -3.72 | -3.72 | 0.0672 | 1.14 | 0.0325 | 0.174 | 5.81 | 46,409.45 | -123.55 | -59.66 | -169.64 | -66.14 | -35.37 | -378.58 | -3,799.22 | -4,046.97 | 2.29 | -- | 0.1086 | -- | -65.28 | 33.02 | 14.64 | -- | 41.94 | -- |
ContextVision AB | 135.27m | 32.90m | 464.85m | 38.00 | 14.13 | 5.36 | 11.24 | 3.44 | 0.4252 | 0.4252 | 1.75 | 1.12 | 1.23 | 2.55 | 3.81 | 3,381,650.00 | 29.83 | 29.39 | 39.15 | 43.27 | 98.08 | 98.58 | 24.32 | 27.15 | 3.40 | -- | 0.044 | -- | 12.19 | 7.78 | -1.77 | -- | -35.88 | -- |
Holder | Shares | % Held |
---|---|---|
Danske Bank A/S (Investment Management Sweden)as of 01 Feb 2024 | 2.05m | 4.53% |
MP Pensjon PKas of 01 Feb 2024 | 1.37m | 3.03% |
SEB Investment Management ABas of 01 Feb 2024 | 185.44k | 0.41% |
Aktia Bank Plc (Investment Management)as of 31 May 2024 | 172.70k | 0.38% |